Evaluation of Alpha-1 Antitrypsin as a Prognostic Biomarker in Severe Influenza: A Prospective Study
Biomolecules · 18.11.2026 · 16 (11) · 1675
DOI: 10.3390/biom16111675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 18.11.2026. Verfasst von Isabel Franco-Burgos und 9 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aragon Health Research Institute.
Abstract (Originalsprache)
Background
Influenza is a global health issue involving inflammatory mediators, the imbalances of which contribute to pulmonary and extrapulmonary damage.
Objectives
To evaluate whether AAT1 levels are elevated in patients with severe influenza and assess its potential as a prognostic biomarker. Materials and methods: A prospective, analytical, non-interventional study was conducted on 72 patients admitted for severe influenza to the Internal Medicine Department at “Lozano Blesa” University Hospital (Zaragoza, Spain). Blood AAT1 concentrations at admission were analyzed alongside clinical and biochemical variables.
Results
The mean patient age was 80.31 years (54.2% female). Overall mortality was 4.17%, one patient required ICU admission, and five had SARS-CoV-2 coinfection. Mean AAT1 concentration was 164.1 mg/dL (normal range: 100–200 mg/dL). AAT1 levels correlated significantly with leukocyte counts and C-reactive protein (r = 0.582, p < 0.001). Leukocyte counts were significantly higher in the patient requiring intensive care. Notably, AAT1 concentrations were significantly higher in patients with SARS-CoV-2 coinfection compared to non-coinfected influenza cases (p < 0.05).
Conclusions
Admission AAT1 concentration does not serve as a useful prognostic biomarker in severe influenza. However, elevated AAT1 levels at diagnosis in hospitalized patients should prompt consideration of SARS-CoV-2 coinfection. Further research is warranted to clarify AAT1 involvement in influenza pathophysiology.
Förderung
- Aragon Health Research Institute
Zitieren
APA
Franco-Burgos, I., Menao-Guillén, S., Perales-Afán, J., García-Gutiérrez, A., Moreno-Gázquez, I., Julián-Ansón, M., Ramos-Álvarez, M., Olivera-González, S., Torralba-Aznárez, S., & Torralba-Cabeza, M. (2026). Evaluation of Alpha-1 Antitrypsin as a Prognostic Biomarker in Severe Influenza: A Prospective Study. Biomolecules, 16(11), 1675. https://doi.org/10.3390/biom16111675
Vancouver
Franco-Burgos I, Menao-Guillén S, Perales-Afán J, García-Gutiérrez A, Moreno-Gázquez I, Julián-Ansón M, et al. Evaluation of Alpha-1 Antitrypsin as a Prognostic Biomarker in Severe Influenza: A Prospective Study. Biomolecules. 2026;16(11):1675. doi:10.3390/biom16111675
BibTeX
@article{FrancoBurgos2026,
author = {Franco-Burgos, Isabel and Menao-Guillén, Sebastián and Perales-Afán, Juan-José and García-Gutiérrez, Almudena and Moreno-Gázquez, Inmaculada and Julián-Ansón, María-Ángel and Ramos-Álvarez, Mónica and Olivera-González, Susana and Torralba-Aznárez, Susana and Torralba-Cabeza, Miguel-Ángel},
title = {Evaluation of Alpha-1 Antitrypsin as a Prognostic Biomarker in Severe Influenza: A Prospective Study},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {11},
pages = {1675},
doi = {10.3390/biom16111675}
}
EUVIMED